You just read:

Eisai Initiates Two Phase III Clinical Studies for Fycompa® (Perampanel) in Young Children With Partial-Onset (Focal) Seizures and Lennox-Gastaut Syndrome

News provided by

Eisai

08 Nov, 2016, 00:01 GMT